SINGLE SHOT CHAMPION
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 210 participants.
Also called NCT05534581
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 210 participants
- Registry
-
NCT05534581
-
- Other papers using this trial's data
- Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05534581. Randomized; no masking; primary purpose treatment. Start 2022-09-26 (actual); primary completion 2025-01-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SINGLE SHOT CHAMPION
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- PVI using the Arctic Front Cryoballoon (Medtronic)
- Intervention (Device)
- PVI using FARAPULSE Pulsed Field Ablation (Boston Scientific)
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- University of Bern
Record details
- Record id
cardio:ct-nct05534581- Content hash
1191dfdeb297ace7d922dafbe8aa661e0b153fa0e2103244981b2b373ac1e5ca